SCHEMBL4935890

SCHEMBL4935890

NNc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29184275 0.97
SCHEMBL976980 0.79 TP53 (0.41)
SCHEMBL84841 0.77
SCHEMBL2845839 0.74
Hydrochloric Acid SCHEMBL28392789 0.74
SCHEMBL11459854 0.74
SCHEMBL6427468 0.74
SCHEMBL18469871 0.74
Bromide SCHEMBL28393345 0.74
SCHEMBL28248488 0.73 GAA (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105770903-B A kind of preparation method of temperature control drug-releasing polymer micro-sphere material 南京理工大学 2019-01-18 CN claimed
CN-109071634-A Antibody coupling matter and its preparation and application R.P.谢勒技术有限责任公司 2018-12-21 CN claimed
WO-2018169953-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME R.P. SCHERER TECHNOLOGIES, LLC (US) 2018-09-20 WO claimed
CN-108264488-A A kind of preparation method for replacing phthalazone class compound 天津瑞岭化工有限公司 2018-07-10 CN claimed
WO-2017189432-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME R.P. SCHERER TECHNOLOGIES, LLC (US) 2017-11-02 WO claimed
US-20170306300-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME ARES CAPITAL CORPORATION, AS COLLATERAL AGENT 2017-10-26 US claimed
US-20250381290-A1 Antibody Conjugates and Methods of Making and Using the Same SCHERER TECHNOLOGIES LLC R P (US) 2025-12-18 US disclosed
US-12296021-B2 Antibody conjugates and methods of making and using the same R.P. SCHERER TECHNOLOGIES, LLC (US) 2025-05-13 US disclosed
US-20240101975-A1 Antibody Conjugates and Methods of Making and Using the Same ARES CAPITAL CORPORATION, AS COLLATERAL AGENT 2024-03-28 US disclosed
US-11788066-B2 Antibody conjugates and methods of making and using the same R.P. SCHERER TECHNOLOGIES, LLC (US) 2023-10-17 US disclosed
CN-110840897-B Metal beta-lactamase inhibitors 河北旺发生物科技有限公司 2023-08-08 CN disclosed
US-20230235079-A1 Antibody Conjugates and Methods of Making and Using the Same R.P. SCHERER TECHNOLOGIES, LLC 2023-07-27 US disclosed
CN-111051309-B Triazolotriazine derivatives useful as A2A receptor antagonists 浙江春禾医药科技有限公司 2023-05-26 CN disclosed
WO-2018169953-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME R.P. SCHERER TECHNOLOGIES, LLC (US) 2018-09-20 WO disclosed
CN-108264488-A A kind of preparation method for replacing phthalazone class compound 天津瑞岭化工有限公司 2018-07-10 CN disclosed
WO-2017189432-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME R.P. SCHERER TECHNOLOGIES, LLC (US) 2017-11-02 WO disclosed
US-20170306300-A1 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME ARES CAPITAL CORPORATION, AS COLLATERAL AGENT 2017-10-26 US disclosed
CN-101812007-B Aminopyrrole compound and preparation method thereof UNIV ZHEJIANG 2011-11-23 CN disclosed
CN-101812007-A Aminopyrrole compound and preparation method thereof UNIV ZHEJIANG 2010-08-25 CN disclosed
US-20080287532-A1 OXACYCLOPENTENE-2 DERIVATIVES SCHWARZ JOSEPH 2008-11-20 US disclosed